Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
79,310,345
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
13,362,668
-
Shares change
-
+320,169
-
Total reported value, excl. options
-
$73,354,516
-
Value change
-
+$1,886,576
-
Put/Call ratio
-
135%
-
Number of buys
-
32
-
Number of sells
-
-33
-
Price
-
$5.48
Significant Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q1 2022
97 filings reported holding CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE as of Q1 2022.
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,362,668 shares
of 79,310,345 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2,423,209 shares), NOMURA HOLDINGS INC (2,403,886 shares), VANGUARD GROUP INC (1,814,275 shares), Elliott Investment Management L.P. (1,550,523 shares), CREDIT SUISSE AG/ (752,683 shares), STATE STREET CORP (686,873 shares), GEODE CAPITAL MANAGEMENT, LLC (661,397 shares), Cresset Asset Management, LLC (329,796 shares), NORTHERN TRUST CORP (323,537 shares), and MORGAN STANLEY (219,851 shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.